Expert consensus on the diagnosis and treatment of colorectal cancer peritoneal metastasis (2025 edition).
10.3760/cma.j.cn441530-20250303-00077
- Collective Name:Colorectal Cancer Professional Committee, Chinese Medical Doctor Association
- Publication Type:Consensus Development Conference
- MeSH:
Humans;
Peritoneal Neoplasms/therapy*;
Colorectal Neoplasms/diagnosis*;
Consensus;
Quality of Life;
Prognosis;
China
- From:
Chinese Journal of Gastrointestinal Surgery
2025;28(5):441-449
- CountryChina
- Language:Chinese
-
Abstract:
Colorectal cancer (CRC) is one of the most common malignant tumors in China, ranking second in morbidity and fourth in mortality. Metastasis and recurrence are the leading causes of patient death, and the peritoneum is a frequent site of metastasis in CRC, second only to liver and lung metastases. However, the prognosis of peritoneal metastasis is much worse than hepatic and pulmonary metastasis. CRC peritoneal metastasis is challenging early diagnosis, presents with severe symptoms, and has a poor prognosis. It is crucial to emphasize standardized diagnosis and treatment for CRC peritoneal metastasis to improve patients' outcome and enhance their quality of life. This consensus, based on evidence-based medical evidence, revised the "Chinese Expert Consensus on the Diagnosis and Treatment of Colorectal Cancer Peritoneal Metastasis (2022 edition)" and reached a preliminary consensus on the definition, diagnosis, treatment, and prevention of CRC peritoneal metastasis, with the aim of guiding and standardizing the diagnosis and treatment of CRC peritoneal metastasis, developing reasonable and effective comprehensive treatment plans, prolonging survival time and improving quality of life for CRC peritoneal metastasis patients, thereby raising the overall level of diagnosis and treatment for CRC in China.
